XML 61 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock Compensation (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity
A summary of employee stock option transactions follows:
Number of
Shares		Weighted-Average
Exercise Price		Weighted-Average
Remaining
Contractual Term
(Years)
Aggregate
Intrinsic
Value (1)
Outstanding on January 1, 20213,822,819 $15.40 4.6$487 
Exercised— $—   
Outstanding on December 31, 20213,822,819 $15.40 3.6$238 
Exercised— $—   
Outstanding on December 31, 20223,822,819 $15.40 2.6$794 
Exercised(1,055,315)$11.47   
Outstanding on December 31, 20232,767,504 $16.89 2.6$146 
Options exercisable at:    
December 31, 20212,988,727    
December 31, 20223,415,944    
December 31, 20232,767,504    
_____________________________
(1)The aggregate intrinsic value represents the amount by which the fair value of the underlying common stock ($11.28, $11.86 and $11.48 as of December 31, 2023, 2022 and 2021, respectively) exceeds the option exercise price.
Schedule of Additional Information Relating to Options Outstanding
Additional information relating to options outstanding as of December 31, 2023 follows:
 Options OutstandingOptions Exercisable
Range of Exercise PricesOutstanding
as of		Weighted-Average
Remaining
Contractual Life
(Years)		Weighted-Average
Exercise Price		Exercisable
as of		Weighted-Average
Remaining
Contractual Life
(Years)		Weighted-Average
Exercise Price		Aggregate Intrinsic Value
12/31/202312/31/2023
$9.86-$11.83406,875 5.2$10.92 406,875 5.2$10.92 $— 
$11.83-$13.80— — $— — — $— $— 
$13.80-$15.77519,278 0.4$14.68 519,278 0.4$14.68 $— 
$15.77-$17.74— — $— — — $— $— 
$17.74-$19.711,841,351 2.6$18.84 1,841,351 2.6$18.84 $— 
 2,767,504 2.6$16.89 2,767,504 2.6$16.89 $146 
Summary of Nonvested Restricted Stock Award Activities
A summary of nonvested restricted stock award activities follows:
Number of SharesWeighted-Average Grant Date Fair Value
Nonvested at January 1, 20231,980,000 $12.24 
Granted (1)
1,335,000 $12.83 
Vested (2)
(613,750)$12.37 
Forfeited— $— 
Nonvested at December 31, 20232,701,250 $12.51 
_____________________________
(1)The weighted-average grant-date fair value of restricted stock awards granted during 2022 and 2021 was $11.11 and $14.31, respectively.
(2)The total fair value of restricted stock awards vested during 2023, 2022, and 2021 was $8,081, $6,125, and $7,492, respectively.